• Astellas C3 Prize Update: Finalists Pitch to Judges at Stanford Medicine X

    Posted in In The News on Sep 25, 2016

    This past April, Astellas Oncology launched the C3 Prize, a challenge aimed at inspiring novel, non-treatment and non-medicine based ideas to change cancer care. The judges included Mark Reisenauer, SVP of the Oncology Business Unit for Astellas Pharma US; Robert Herjavec, IT Entrepreneur, Founder & CEO of the Herjavec Group and star of ABC’s “Shark Tank”; Chris Coburn, Vice President of Innovation at Partners HealthCare and host of the World Medical Innovation Forum; and Michael Seres, who is ePatient-in-Residence and Executive Board Member for Stanford Medicine X. Five finalists pitched at t...

  • Changing Cancer Care at Stanford Medicine X

    Posted in In The News on Sep 19, 2016

    The past weekend we spent at Stanford Medicine X, listening to interesting and inspiring talks, and interacting with a diverse group of people and the ideas they brought with them. The event is designed to bring people from all aspects of medical care, including doctors and nurses, patients and caretakers, insurance reps, hospital administrators, policy makers, product designers, and many others. It was somewhat overwhelming, but because different rooms were used to host presentations in parallel we were able to choose which discussions to attend.

  • Changing Cancer Care

    Posted in Articles on Sep 12, 2016

    According to the World Health Organization (WHO), cancer is now the leading cause of death worldwide, with approximately 14 million new cases and 8.2 million fatalities annually, which is predicted to grow by 70% over the next 20 years. (World Health Organization , 2015) Four problems profoundly impact cancer clinical outcomes in the world today: (1) non-adherence, because of increasing use of oral cancer agents; (2) coordinating care, because cancer care is team-based across disparate providers (poly-pharmacy & poly-provider); (3) drug-drug interactions, because at least 2.24 million cancer p...

  • Astellas Oncology C3 Prize Finalist

    Posted in In The News on Sep 12, 2016

    Bioinformatix has been selected as one of five finalists for the Astellas Oncology's C3 Prize.

  • Personalized Medicine Will Drive Cloud Computing Over the 60% Adoption Ceiling in Healthcare Organizations

    Posted in Articles on Aug 25, 2016

    The colloquialism of “cloud computing” is so broad as to often mean different things to different people; however, generally refers to the tectonic shift that has occurred in information technology in the last 10 years from predominantly client-server or private network-based systems, to software-as-a-service (SaaS) that is delivered via the Internet. The broad range of IT and related services that can be included in “cloud computing” include, but are not limited to, email providers (e.g., Gmail), software applications (e.g., Microsoft 365), phones systems and voice mails (e.g., Cisco), colla...